title: Differential effect of high-dose naloxone on the plasma adrenaline response to the cold-pressor test.
abstract: 1. Although the opiate antagonist naloxone has been shown to affect sympathoadrenomedullary function in some studies, this has not been a uniform finding in all investigations, using different doses of naloxone. We have therefore investigated the actions of saline placebo and increasing bolus doses of intravenous naloxone (25, 100 and 250 micrograms/kg) on the plasma noradrenaline, adrenaline, adrenocorticotrophin (ACTH) and cortisol responses to a cold-pressor test in six males and two females in a double-blind randomized study. 2. Basal levels of adrenaline did not differ on any of the study occasions: the cold-pressor stimulus produced a significant rise in mean plasma adrenaline to a peak of 0.16 nmol/l, with a peak incremental rise of 0.08 nmol/l. In the presence of the two higher doses of naloxone, the incremental rise in the mean adrenaline level was significantly enhanced, reaching 0.30 nmol/l at 100 micrograms of naloxone/kg and 0.29 nmol/l at 250 micrograms of naloxone/kg, with no significant enhancement observed at the lowest dose of naloxone. The rise in plasma noradrenaline, systolic and diastolic blood pressure and pulse rate during the cold-pressor test was not consistently altered by any dose of naloxone, but there was a significant trend for the degree of discomfort to increase with the dose of naloxone. 3. Neither plasma ACTH nor serum cortisol rose in response to the cold-pressor stimulus.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Endocrinology, St Bartholomew's Hospital, London.
authors.forename: P M
authors.initials: PM
authors.lastname: Bouloux
authors.forename: E
authors.initials: E
authors.lastname: Newbould
authors.forename: R
authors.initials: R
authors.lastname: Causon
authors.forename: L
authors.initials: L
authors.lastname: Perry
authors.forename: L H
authors.initials: LH
authors.lastname: Rees
authors.forename: G M
authors.initials: GM
authors.lastname: Besser
authors.forename: A
authors.initials: A
authors.lastname: Grossman
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood*; D005260:Female; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology*; D009638:Norepinephrine / Q000097:blood; D011897:Random Allocation; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology
chemical_list: D009270:Naloxone; D000324:Adrenocorticotropic Hormone; D009638:Norepinephrine; D004837:Epinephrine